Literature DB >> 26645117

Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.

Valentín Manríquez1, Rodrigo Guzmán2, Michel Naser2, Amalia Aguilera2, Simonie Narvaez2, Ariel Castro3, Steven Swift4, G Alessandro Digesu5.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of this study was to evaluate the effectiveness of transcutaneous posterior tibial nerve stimulation (T.C. PTNS) versus extended release oxybutynin (E.R.O.) in patients with overactive bladder.
MATERIALS AND METHODS: Seventy female patients were randomized to receive either 10mg E.R.O. daily or T.C. PTNS, using a TENS machine program with the 20Hz, 200 cycles/s, and normal stimulation setting for two 30-min sessions, each week for a 12-week period. Pre-treatment and after the 12-week intervention, each patient completed a 3-day voiding diary and a self-report quality of life questionnaire (OAB-q). Statistical analysis was performed using Stata V12.1.
RESULTS: Sixty-four patients completed the treatment protocol. There were no significant differences between study groups in terms of age, body mass index, past hormone replacement therapy, smoking habits, menopause status, and parity. Prior to treatment, there were also no significant differences in the analysis of the 3-day voiding diary or in the OAB-q questionnaire results. Following the 12-week study, there was a statistically significant reduction in frequency of urination, urgency episodes, and urge incontinent episodes compared to pre-treatment values. However, there were no significant differences in these values between intervention groups after 12-weeks of therapy. There was a similar improvement in OAB-q scores in both treatment groups following therapy, and the T.C. PTNS group showed a statistically significant improvement over the E.R.O. in domain 2 of the OAB-q questionnaire. The other two domains showed similar improvement in both study groups.
CONCLUSION: T.C. PTNS and E.R.O. demonstrated similar improvements in subjects with OAB in a 12-week study.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Neuromodulation; Overactive bladder; Quality of life

Mesh:

Substances:

Year:  2015        PMID: 26645117     DOI: 10.1016/j.ejogrb.2015.09.020

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  14 in total

Review 1.  Randomized clinical trials assessing third-line therapies to treat non-neurogenic overactive bladder syndrome: a review about methodology.

Authors:  Pierre-Luc Dequirez; Xavier Biardeau
Journal:  Int Urogynecol J       Date:  2021-03-26       Impact factor: 2.894

2.  Tibial nerve stimulation to inhibit the micturition reflex by an implantable wireless driver microstimulator in cats.

Authors:  Xing Li; Li-Min Liao; Guo-Qing Chen; Zhao-Xia Wang; Tian-Ji Lu; Han Deng; Gerald-E Loeb
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

3.  Characterizing the transcutaneous electrical recruitment of lower leg afferents in healthy adults: implications for non-invasive treatment of overactive bladder.

Authors:  Eshani Sharan; Kelly Hunter; Magdy Hassouna; Paul B Yoo
Journal:  BMC Urol       Date:  2018-02-13       Impact factor: 2.264

4.  Posterior tibial nerve stimulation for overactive bladder-techniques and efficacy.

Authors:  Alka A Bhide; Visha Tailor; Ruwan Fernando; Vik Khullar; Giuseppe Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2019-12-18       Impact factor: 2.894

5.  Real-life patient experiences of TTNS in the treatment of overactive bladder syndrome.

Authors:  Manon Te Dorsthorst; Michael van Balken; Dick Janssen; John Heesakkers; Frank Martens
Journal:  Ther Adv Urol       Date:  2021-08-31

6.  Tibial nerve stimulation compared with sham to reduce incontinence in care home residents: ELECTRIC RCT.

Authors:  Joanne Booth; Lorna Aucott; Seonaidh Cotton; Bridget Davis; Linda Fenocchi; Claire Goodman; Suzanne Hagen; Danielle Harari; Maggie Lawrence; Andrew Lowndes; Lisa Macaulay; Graeme MacLennan; Helen Mason; Doreen McClurg; John Norrie; Christine Norton; Catriona O'Dolan; Dawn Skelton; Claire Surr; Shaun Treweek
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

Review 7.  Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome.

Authors:  Liesbeth L de Wall; John Pfa Heesakkers
Journal:  Res Rep Urol       Date:  2017-08-14

Review 8.  Neuromodulation - a therapeutic option for refractory overactive bladder. A recent literature review.

Authors:  Jacek K Szymański; Aneta Słabuszewska-Jóźwiak; Kornelia Zaręba; Grzegorz Jakiel
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-05-23       Impact factor: 1.195

9.  Different electrode positioning for transcutaneous electrical nerve stimulation in the treatment of urgency in women: a study protocol for a randomized controlled clinical trial.

Authors:  Juliana Falcão Padilha; Mariana Arias Avila; Enio Júnior Seidel; Patricia Driusso
Journal:  Trials       Date:  2020-02-11       Impact factor: 2.279

10.  The long-lasting post-stimulation inhibitory effects of bladder activity induced by posterior tibial nerve stimulation in unanesthetized rats.

Authors:  Eunkyoung Park; Jae-Woong Lee; Taekyung Kim; Minhee Kang; Baek Hwan Cho; Jiho Lee; Sung-Min Park; Kyu-Sung Lee
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.